Level of alexithymia as a measure of personality dysfunction in avoidant personality disorder.


Journal

Nordic journal of psychiatry
ISSN: 1502-4725
Titre abrégé: Nord J Psychiatry
Pays: England
ID NLM: 100927567

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 5 11 2020
medline: 7 5 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

Avoidant Personality Disorder (AvPD) is considered a mild to moderate personality disorder. However, few studies have focused on the heterogeneity of AvPD in terms of symptoms and severity. In the current study we set out to replicate and extend earlier findings showing that there is variation among patients with AvPD in terms of alexithymia and, further, that this variation is especially associated with specific facets of personality functioning and is not explained by measures of depression, symptom severity, or co-occurring personality disorder traits. We used intake data from a sample of AvPD patients ( Using well-established cut-off points for low, intermediate and high levels of alexithymia we found an almost equal distribution of alexithymia groups in our sample. Alexithymia was associated with higher personality dysfunction on twelve out of sixteen facets of personality functioning. For eight of these personality facets the alexithymia total score explained significant variance even after controlling for self-reported depression, symptom severity and clinician ratings of personality disorder. Results suggest that AvPD is heterogeneous and that alexithymia may be important as an indicator of severity of specific personality dysfunction.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Avoidant Personality Disorder (AvPD) is considered a mild to moderate personality disorder. However, few studies have focused on the heterogeneity of AvPD in terms of symptoms and severity. In the current study we set out to replicate and extend earlier findings showing that there is variation among patients with AvPD in terms of alexithymia and, further, that this variation is especially associated with specific facets of personality functioning and is not explained by measures of depression, symptom severity, or co-occurring personality disorder traits.
METHOD METHODS
We used intake data from a sample of AvPD patients (
RESULTS AND CONCLUSIONS CONCLUSIONS
Using well-established cut-off points for low, intermediate and high levels of alexithymia we found an almost equal distribution of alexithymia groups in our sample. Alexithymia was associated with higher personality dysfunction on twelve out of sixteen facets of personality functioning. For eight of these personality facets the alexithymia total score explained significant variance even after controlling for self-reported depression, symptom severity and clinician ratings of personality disorder. Results suggest that AvPD is heterogeneous and that alexithymia may be important as an indicator of severity of specific personality dysfunction.

Identifiants

pubmed: 33146059
doi: 10.1080/08039488.2020.1841290
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

266-274

Auteurs

Sebastian Simonsen (S)

Stolpegaard Psychotherapy Centre, Gentofte, Denmark.

Ingeborg Ullveit-Moe Eikenaes (IU)

National Advisory unit for Personality Psychiatry (NAPP), Oslo University Hospital, Oslo, Norway.

Bo Bach (B)

Center for Personality Disorder Research, Psychiatric Research Unit, Region Zealand, Slagelse, Denmark.

Elfrida Kvarstein (E)

Section for Personality Psychiatry and Specialized Treatments, Oslo University Hospital/Institute for Clinical medicine, University of Oslo, Oslo, Norway.

Matthias Gondan (M)

Stolpegaard Psychotherapy Centre, Gentofte, Denmark.

Stine Bjerrum Møller (SB)

Stolpegaard Psychotherapy Centre, Gentofte, Denmark.

Theresa Wilberg (T)

Department for Research and Innovation, Clinic for Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH